Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
03/03/2026 07:28
March 3 (Reuters) - SynAct Pharma AB SYNACT.ST: SAID ON MONDAY CARRIED OUT DIRECTED ISSUE OF NEW SHARES OF ABOUT SEK 51.9 MLN SUBSCRIPTION PRICE WAS SET AT SEK 18.00 PER SHARE NET PROCEEDS WILL BE USED TO CREATE INCREASED FINANCIAL FLEXIBILITY, TO FUND EXTENSION OF RUNWAY TO SUPPORT POST-DATA PARTNERING DISCUSSIONS Source text for Workspace: nNDLcfs30x Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026